A Review of NEPA, a Novel Fixed Antiemetic Combination with the Potential for Enhancing Guideline Adherence and Improving Control of Chemotherapy-Induced Nausea and Vomiting

Lignende værker

• Practice Patterns for Prevention of Chemotherapy‐Induced Nausea and Vomiting and Antiemetic Guideline Adherence Based on Real‐World Prescribing Data
  af: Aapro, Matti, et al.
  Udgivet: (2021)
• Timing flexibility of oral NEPA, netupitant-palonosetron combination, administration for the prevention of chemotherapy-induced nausea and vomiting (CINV)
  af: Baron-Hay, Sally, et al.
  Udgivet: (2019)
• Preventing chemotherapy-induced nausea and vomiting in patients with lung cancer: efficacy of NEPA (netupitant-palonosetron), the first combination antiemetic
  af: Hesketh, Paul J., et al.
  Udgivet: (2017)
• Fixed combination of oral NEPA (netupitant‐palonosetron) for the prevention of acute and delayed chemotherapy‐induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double‐blind phase III studies
  af: Schwartzberg, Lee, et al.
  Udgivet: (2019)
• Prevention of nausea and vomiting in cancer patients
  af: Aapro, Matti., et al.
  Udgivet: (2013.)